These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17117089)

  • 1. Focal F-18 FDG uptake mimicking malignant gastric localizations disappearing after water ingestion on PET/CT images.
    Imperiale A; Cimarelli S; Sellem DB; Blondet C; Contantinesco A
    Clin Nucl Med; 2006 Dec; 31(12):835-7. PubMed ID: 17117089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
    Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD
    J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-D-glucose PET.
    Kamimura K; Nagamachi S; Wakamatsu H; Fujita S; Nishii R; Umemura Y; Ogita M; Komada N; Sakurai T; Inoue T; Fujimoto T; Nakajo M
    Nucl Med Commun; 2009 Jun; 30(6):431-9. PubMed ID: 19352209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal FDG uptake in the gastric contents: a PET/CT misregistration artifact due to vesicant use and water loading.
    Kao PF; Chou YH; Hsieh KY
    Clin Nucl Med; 2008 Mar; 33(3):231-3. PubMed ID: 18287858
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avoidance of misinterpretation of an FDG positive sacral insufficiency fracture using PET/CT scans in a patient with endometrial cancer: a case report.
    Halaç M; Mut SS; Sönmezoglu K; Ylmaz MH; Ozer H; Uslu I
    Clin Nucl Med; 2007 Oct; 32(10):779-81. PubMed ID: 17885357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
    Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S
    Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.
    Sun XG; Huang G; Liu JJ; Wan LR
    Hell J Nucl Med; 2009; 12(2):115-8. PubMed ID: 19675862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
    Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
    J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric Schwannoma mimicking malignant gastrointestinal stromal tumor and misdiagnosed by (18)F-FDG PET/CT.
    Zhang Y; Li B; Cai L; Hou X; Shi H; Hou J
    Hell J Nucl Med; 2015; 18(1):74-6. PubMed ID: 25840576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal 18F-FDG accumulation on PET without a corresponding CT abnormality is not an early indicator of cancer development.
    Heusner TA; Hahn S; Hamami ME; Kim UH; Baumeister R; Forsting M; Stahl A; Bockisch A; Antoch G
    Eur Radiol; 2009 Sep; 19(9):2171-9. PubMed ID: 19415294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
    Israel O; Yefremov N; Bar-Shalom R; Kagana O; Frenkel A; Keidar Z; Fischer D
    J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG avidity and PET/CT patterns in primary gastric lymphoma.
    Radan L; Fischer D; Bar-Shalom R; Dann EJ; Epelbaum R; Haim N; Gaitini D; Israel O
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1424-30. PubMed ID: 18418594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid splenic masses: evaluation with 18F-FDG PET/CT.
    Metser U; Miller E; Kessler A; Lerman H; Lievshitz G; Oren R; Even-Sapir E
    J Nucl Med; 2005 Jan; 46(1):52-9. PubMed ID: 15632034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET in a case of multiple bone metastases of gastric cancer.
    Nakai T; Okuyama C; Kubota T; Ushijima Y; Nishimura T
    Ann Nucl Med; 2005 Feb; 19(1):51-4. PubMed ID: 15770974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results.
    Kamel EM; Thumshirn M; Truninger K; Schiesser M; Fried M; Padberg B; Schneiter D; Stoeckli SJ; von Schulthess GK; Stumpe KD
    J Nucl Med; 2004 Nov; 45(11):1804-10. PubMed ID: 15534047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of 18F-FDG PET/CT uptake patterns in Waldeyer's ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx.
    Chen YK; Su CT; Chi KH; Cheng RH; Wang SC; Hsu CH
    J Nucl Med; 2007 Jan; 48(1):8-14. PubMed ID: 17204693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
    Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y
    Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.